viewKidman Resources Ltd

Kidman Resources continues to ride lithium wave by signing offtake agreement with Tesla

Electric vehicle maker signs agreement to secure lithium hydroxide from proposed new refinery in Western Australia.

Tesla sign and EV
The company is also in discussions with other interested offtake parties

Kidman Resources Ltd (ASX:KDR) continues to ride high on the lithium wave and the latest crest is the signing of a lithium hydroxide offtake agreement with electric vehicle giant Tesla.

The binding agreement is for an initial term of three years on a fixed-price take-or-pay basis from the delivery of first product and contains two three-year term options.

Company has integrated lithium strategy

It further validates Kidman’s strategy of being an integrated manufacturer of battery-grade refined lithium.

Investors have demonstrated their support of the strategy with shares up 8% intra-day to $2.34 on volume of more than 9 million.

Recent news flow has seen Kidman reach a 12-month high of $2.37 earlier this month.

READ: Kidman Resources selects site at Kwinana for proposed lithium refinery

The Tesla agreement follows Western Australia Lithium (WAL), Kidman’s 50:50 joint venture with Sociedad Quimica y Minera de Chile (SQM), signing an option to lease land for a proposed lithium refinery.

WAL has entered into an exclusive option to lease a premier site in the Kwinana Strategic Industrial Area in Western Australia.

The Tesla agreement equates to less than 25% of Kidman’s portion of initial nameplate production for the first three years from the refinery.

Others seek refined lithium offtake

In addition to this agreement, Kidman is in discussions with other strategic, globally significant parties also seeking refined lithium offtake.

Expressions of interest to date have materially exceeded Kidman’s portion of initial refinery nameplate production.

Kidman is targeting to enter into a limited number of offtake agreements while leaving a minority portion of future supply uncontracted.

Quick facts: Kidman Resources Ltd

Price: - -

Market: ASX
Market Cap: -

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...


Bionomics' positive pharmacokinec results confirms it can begin second Phase...

Bionomics Limited (ASX:BNO) (OTCQB:BNOEF) Executive Chairman Errol De Souza tells Proactive tells Proactive the Adelaide, Australia- based biopharmaceutical company has received positive pharmacokinetic results from a 7-day dosing study to treat PTSD, using its new formulation of BNC210. De...

15 hours, 37 minutes ago

2 min read